title: Re: "Erythema Annulare Centrifugum due to Pegylated Interferon-α-2a plus Ribavirin Combination Therapy in a Patient with Chronic Hepatitis C Virus Infection".
authors.forename: Mark
authors.initials: M
authors.lastname: Naccarato
authors.forename: Deborah
authors.initials: D
authors.lastname: Yoong
authors.forename: Robert
authors.initials: R
authors.lastname: Solomon
authors.forename: Mario
authors.initials: M
authors.lastname: Ostrowski
mesh_terms: D004890:Erythema / Q000139:chemically induced*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D011092:Polyethylene Glycols / Q000009:adverse effects*; D012254:Ribavirin / Q000009:adverse effects*; D012873:Skin Diseases, Genetic / Q000139:chemically induced*
chemical_list: D016898:Interferon-alpha; D011092:Polyethylene Glycols; D012254:Ribavirin